宏利香港首季核心盈利按年升17%至17億元
宏利金融(00945.HK)旗下宏利香港公布2021年首季業績,核心盈利按年升17%至17億元;季內年度化保費等值銷售額增長10%至17億元;新造業務價值增長18%至11億元。截至3月底止,代理人共10,690人,較2020年首季末增長6%。
截至2021年3月底止,按管理資產計算,宏利的強積金市佔率創下24.7%的新高,較2020年首季末增長0.7個百分點。
宏利香港首席行政總監戴明鈞稱,公司首季在核心盈利、年度化保費等值銷售額、新造業務價值方面都錄得雙位數升幅。隨著限制措施自本年2月起開始放寬,公司在各分銷渠道的銷售活動亦迅速回升,當中尤以銀行及保持卓越生產力的代理人團隊最為顯著。
他續稱,除了可扣稅方案,市場對公司的儲蓄計劃及危疾產品的需求也持續增長。季內危疾產品銷售額也大幅上升約40%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.